Adalimumab: Injection 40 mg in 0.4 mL pre-filled syringe, Injection 40 mg in 0.4 mL pre-filled pen; Hadlima® Page last updated: 1 March 2024 Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 371KB) Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 54KB)